O
Olema Pharmaceuticals, Inc. (OLMA)
NMS – Real Time Price. Currency in USD
11.39
-0.04 (-0.35%)
At close: Jun 26, 2026, 4:00 PM EDT
11.17
-0.22 (-1.93%)
After-hours: Jun 26, 2026, 5:08 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
11.39
-0.04 (-0.35%)
At close: Jun 26, 2026, 4:00 PM EDT
11.17
-0.22 (-1.93%)
After-hours: Jun 26, 2026, 5:08 PM EDT
| Breakdown | |
|---|---|
| 1.80% | % of Shares Held by All Insider |
| 119.42% | % of Shares Held by Institutions |
| 121.61% | % of Float Held by Institutions |
| 265 | Number of Institutions Holding Shares |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| FMR, LLC | 10.39M | 2026-03-31 | 11.89% | $117.48M |
| Paradigm Biocapital Advisors LP | 8.02M | 2026-03-31 | 9.18% | $90.71M |
| Bain Capital Life Sciences Investors, LLC | 7.47M | 2026-03-31 | 8.56% | $84.52M |
| Janus Henderson Group PLC | 7.11M | 2026-03-31 | 8.14% | $80.40M |
| Blackrock Inc. | 5.65M | 2026-03-31 | 6.47% | $63.93M |
| BVF Inc. | 5.30M | 2026-03-31 | 6.06% | $59.90M |
| Siren, L.L.C. | 4.76M | 2026-03-31 | 5.45% | $53.80M |
| State Street Corporation | 3.94M | 2026-03-31 | 4.51% | $44.54M |
| Cormorant Asset Management, LP | 3.90M | 2026-03-31 | 4.46% | $44.11M |
| Logos Global Management LP | 3.21M | 2026-03-31 | 3.67% | $36.29M |
| Vanguard Capital Management LLC | 3.08M | 2026-03-31 | 3.53% | $41.90M |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.74M | 2026-05-31 | 3.13% | $30.95M |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.43M | 2026-03-31 | 2.78% | $27.45M |
| iShares Trust-iShares Russell 2000 ETF | 1.65M | 2026-04-30 | 1.89% | $18.67M |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.50M | 2026-04-30 | 1.72% | $16.97M |
| Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. | 1.11M | 2026-04-30 | 1.27% | $12.56M |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.00M | 2026-02-28 | 1.15% | $14.97M |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 893,200 | 2025-10-31 | 1.02% | $12.14M |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 777,200 | 2026-04-30 | 0.89% | $8.79M |
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | 772,189 | 2025-10-31 | 0.89% | $10.50M |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 750,000 | 2026-04-30 | 0.86% | $8.48M |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 665,222 | 2026-05-31 | 0.76% | $7.52M |
| T. Rowe Price Health Sciences Fund, Inc. | 649,181 | 2026-03-31 | 0.74% | $7.34M |
| Columbia Funds Series Trust I-Columbia Small Cap Value Discovery Fund | 633,768 | 2025-10-31 | 0.92% | $15.43M |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 628,100 | 2026-04-30 | 0.72% | $7.10M |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 605,022 | 2025-11-30 | 0.88% | $14.39M |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 569,000 | 2025-12-31 | 0.83% | $13.77M |